当前位置:
X-MOL 学术
›
Indian J. Biochem. Biophys.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Biomarker profile in pediatric inflammatory multisystem syndrome temporarily associated with SARS-CoV-2 (PIMS-TS)/multisystem inflammatory syndrome in children (MIS-C)
Indian Journal of Biochemistry and Biophysics ( IF 1.5 ) Pub Date : 2020-11-23 Surupa Basu, Arunaloke Bhattacharyya, Kshounish Ray, Apurba Ghosh
Indian Journal of Biochemistry and Biophysics ( IF 1.5 ) Pub Date : 2020-11-23 Surupa Basu, Arunaloke Bhattacharyya, Kshounish Ray, Apurba Ghosh
Pediatric Inflammatory Multisystem Syndrome temporarily associated with SARS-CoV-2 (PIMS-TS) or Multisystem Inflammatory Syndrome in Children (MIS-C) is a post COVID-19 multisystem inflammatory syndrome in children and adolescents <21 years of age. It is slowly emerging in India with clinical features overlapping with Kawasaki Disease (KD) and Toxic Shock Syndrome (TSS). Ten PIMS-TS cases admitted in a pediatric hospital between July and Sept 2020 were compared with 19 Kawasaki Disease (KD) patients’ data. The median age of PIMS-TS was 6 years (older to KD), 80% were males. PMS-TS cases had high inflammatory markers: CRP, ferritin, interleukin (IL)-6. Other distinct features were lymphopenia, hypoalbuminemia, and hyponatremia. Serial measurements of CRP showed high baseline values with subsequent decrease. NT-Pro BNP level was extremely elevated; suggestive of cardiac injury. All patients recovered. Laboratory features of PIMS-TS present a unique pattern of intense inflammation, and cardiac involvement that is different from features of pre COVID-19 KD. CRP remains a useful, inexpensive marker for PIMS-TS diagnosis and clinical progression.
中文翻译:
暂时与儿童SARS-CoV-2(PIMS-TS)/儿童多系统炎症综合症(MIS-C)相关的儿童炎症多系统综合症的生物标志物概况
暂时与SARS-CoV-2(PIMS-TS)或儿童多系统炎症综合症(MIS-C)相关的小儿炎症多系统综合症是COVID-19后21岁以下儿童和青少年的多系统炎症综合症。它在印度正在慢慢出现,其临床特征与川崎病(KD)和毒性休克综合症(TSS)重叠。将2020年7月至2020年9月间在儿科医院收治的10例PIMS-TS患者与19例川崎病(KD)患者的数据进行比较。PIMS-TS的中位年龄为6岁(比KD大),男性占80%。PMS-TS病例具有较高的炎症标记:CRP,铁蛋白,白介素(IL)-6。其他明显特征是淋巴细胞减少症,低白蛋白血症和低钠血症。CRP的串行测量显示较高的基线值,随后降低。NT-Pro BNP水平极高;提示心脏损伤。所有患者均康复。PIMS-TS的实验室特征呈现出强烈的炎症和心脏受累的独特模式,这与COVID-19 KD之前的特征不同。CRP仍然是PIMS-TS诊断和临床进展的有用,廉价的标记物。
更新日期:2020-11-23
中文翻译:
暂时与儿童SARS-CoV-2(PIMS-TS)/儿童多系统炎症综合症(MIS-C)相关的儿童炎症多系统综合症的生物标志物概况
暂时与SARS-CoV-2(PIMS-TS)或儿童多系统炎症综合症(MIS-C)相关的小儿炎症多系统综合症是COVID-19后21岁以下儿童和青少年的多系统炎症综合症。它在印度正在慢慢出现,其临床特征与川崎病(KD)和毒性休克综合症(TSS)重叠。将2020年7月至2020年9月间在儿科医院收治的10例PIMS-TS患者与19例川崎病(KD)患者的数据进行比较。PIMS-TS的中位年龄为6岁(比KD大),男性占80%。PMS-TS病例具有较高的炎症标记:CRP,铁蛋白,白介素(IL)-6。其他明显特征是淋巴细胞减少症,低白蛋白血症和低钠血症。CRP的串行测量显示较高的基线值,随后降低。NT-Pro BNP水平极高;提示心脏损伤。所有患者均康复。PIMS-TS的实验室特征呈现出强烈的炎症和心脏受累的独特模式,这与COVID-19 KD之前的特征不同。CRP仍然是PIMS-TS诊断和临床进展的有用,廉价的标记物。